Breast Cancer Breakthroughs: The Importance Of Esr1 Mutations In Metastatic Breast Cancer

Breast Cancer Breakthroughs: The Importance of ESR1 mutations in metastatic breast cancer

Susan G. Komen®

ESR1 Mutations in Metastatic Breast Cancer: Should I get tested?

Dr. Fuqua on ESR1 Mutations in Primary Breast Cancer

Targeted Oncology

ESR1 Mutation: The Need for & Role of Testing in ER+/ HER2- Advanced or Metastatic Breast Cancer

COR2ED The Heart of Medical Education

ELAINE 1: ESR1 mutations in ctDNA from ER+/HER2- mBC treated with lasofoxifene or fulvestrant

Exploring Breakthrough Treatments in Metastatic Breast Cancer

Breast Cancer Research Foundation

Breast Cancer Breakthroughs Episode 7: Bringing Treatments to Life

Susan G. Komen®

Top 5 Breast/GYN Cancer Advances in 2023: #2 Metastatic Breast Cancer Drug Approvals

Eleonora Teplinsky

Dr. Graff Underscores Unmet Needs in ESR1-Mutated Breast Cancer

Dr. Goncalves Describes Research Involving the ESR1 Mutation in Breast Cancer

Understanding Progression: How to Identify and Treat ESR1 Mutations in HR+ MBC

SHARE Cancer Support

Medical advances in the treatment of metastatic breast cancer

Living Beyond Breast Cancer

Breast Cancer Breakthroughs: Treatment Gap Filled by the EMERALD Clinical Trial

Susan G. Komen®

Foundation Frontiers: Advanced Breast Cancer - Updates to HR+/HER2- Treatment Landscape

Foundation Medicine

Personalized medicine: The role of testing in metastatic breast cancer

Living Beyond Breast Cancer

AMEERA-3: SERD for ER+ HER2- breast cancer

Estrogen signaling in breast cancer

Science in Motion

ASCO 2022: Metastatic Breast Cancer Drug Therapy Recap

Hopeful Advances In Metastatic Breast Cancer

Concord Hospital Health System

Metastatic Breast Cancer: What You Need to Know

Cancer Informant